Home/Filings/4/0001415889-24-000648
4//SEC Filing

Bergmann Anthony 4

Accession 0001415889-24-000648

CIK 0001133869other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:15 PM ET

Size

8.4 KB

Accession

0001415889-24-000648

Insider Transaction Report

Form 4
Period: 2024-01-02
Bergmann Anthony
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-02+9,6929,692 total
    Exercise: $5.12Exp: 2034-01-02Common Stock (9,692 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-01-02+85,00085,000 total
    Exercise: $5.12Exp: 2034-01-02Common Stock (85,000 underlying)
Footnotes (2)
  • [F1]The shares vest 1/48th of the first day of each month, commencing February 1, 2024, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.
  • [F2]The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant.

Issuer

CAPRICOR THERAPEUTICS, INC.

CIK 0001133869

Entity typeother

Related Parties

1
  • filerCIK 0001593087

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:15 PM ET
Size
8.4 KB